Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Filings indexed 418 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
주권매매거래정지해제 (액면병합 주권 변경상장)
Regulatory Filings Classification · 85% confidence The document is a short regulatory announcement in Korean regarding the lifting of a trading suspension on shares (“주권매매거래정지해제”) under specific exchange rules. It does not constitute a full financial report but is an exchange notice. This fits the general Regulatory Filings fallback category (RNS).
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제 13기) 2026년 01월 01일–2026년 03월 31일” and contains detailed sections typical of a quarterly securities report (company overview, business description, shareholding, management changes, and likely financial statements). It is not merely an announcement or link to a report but is the full interim/quarterly report itself. Therefore, it matches the definition of Interim / Quarterly Report (Code: IR). Q1 2026
2026-05-14 Korean
[기재정정]주주총회소집결의
Regulatory Filings
2026-05-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-04 Korean
주식등의대량보유상황보고서(약식)
Regulatory Filings
2026-05-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.